Search research articles
Contact Us
Filters
Showing results (101-110 of 167) with videos related to
Page
of 17
Sort By:
American Journal of Human Genetics
|
August 5, 2014
Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes
Yukinori Okada, Buhm Han, Lam C Tsoi, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 12, 2017
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86)
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Cancers
|
June 2, 2021
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study
Henner Stege, Maximilian Haist, Michael Schultheis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2026
Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG
Konstantinos Lallas, Lena Nanz, Selma Ugurel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2021
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
Carl M Thielmann, Johanna Matull, Anne Zaremba, et al.
Nature Genetics
|
October 19, 2010
Genome-wide association analysis identifies three psoriasis susceptibility loci
Philip E Stuart, Rajan P Nair, Eva Ellinghaus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2018
Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study
Sara Valpione, Matteo S Carlino, Johanna Mangana, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2018
Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124]
Sara Valpione, Matteo S Carlino, Johanna Mangana, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 11, 2023
Characterisation and outcome of RAC1 mutated melanoma
Georg C Lodde, Philipp Jansen, Rudolf Herbst, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis
Glenn Geidel, Sabrina Bänsch, Laura Adam, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 167) with videos related to
Sort By:
Page
of 17
American Journal of Human Genetics
|
August 5, 2014
Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes
Yukinori Okada, Buhm Han, Lam C Tsoi, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 12, 2017
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86)
Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Cancers
|
June 2, 2021
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study
Henner Stege, Maximilian Haist, Michael Schultheis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2026
Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG
Konstantinos Lallas, Lena Nanz, Selma Ugurel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2021
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
Carl M Thielmann, Johanna Matull, Anne Zaremba, et al.
Nature Genetics
|
October 19, 2010
Genome-wide association analysis identifies three psoriasis susceptibility loci
Philip E Stuart, Rajan P Nair, Eva Ellinghaus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2018
Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study
Sara Valpione, Matteo S Carlino, Johanna Mangana, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2018
Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124]
Sara Valpione, Matteo S Carlino, Johanna Mangana, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 11, 2023
Characterisation and outcome of RAC1 mutated melanoma
Georg C Lodde, Philipp Jansen, Rudolf Herbst, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis
Glenn Geidel, Sabrina Bänsch, Laura Adam, et al.
Page
of 17